Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: TWIST2 and the PPAR signaling pathway are important in the progression of nonalcoholic steatohepatitis

Fig. 1

Characterization of an in vivo model of fatty liver disease and changes in TWIST1, TWIST2 and PPARĪ³ protein expression in the liver (nā€‰=ā€‰8). a Comparison of the sizes of control and high-fat diet (HFD) group mice and their livers. b H&E staining of livers from control and HFD mice.c Oil red O staining of livers from control and HFD group mice. d Changes in body weight over time. e Intraperitoneal glucose tolerance test (IPGTT). f Intraperitoneal insulin tolerance test (IPITT). g Relative protein levels of TWIST1, TWIST2 and PPARĪ³ in the livers of control and HFD group mice. The arrow shows that the upper band is the true Twist1. H/I/J) Semiquantitative assays of TWIST1 (h), TWIST2 (i), and PPARĪ³ (j) in the livers of control and HFD group mice

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X